Antipsychotic treatment based on SNP genotype

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9458507
APP PUB NO 20160265060A1
SERIAL NO

15085778

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the prediction of antipsychotic treatment efficacy based on a patient's genotype at one or more single nucleotide polymorphism (SNP) loci and to the treatment of a patient based on such prediction.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VANDA PHARMACEUTICALS INC2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lavedan, Christian Potomac, US 44 72
Licamele, Louis Potomac, US 17 35
Polymeropoulos, Mihael H Potomac, US 136 427
Volpi, Simona Derwood, US 25 42

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 4, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00